Corwave

Corwave

Implantable heart pump for heart failure

Overview

Corwave develops implantable cardiac support devices to help heart failure patients. Its main product is an implantable heart pump that uses wave membrane pumping technology, where an oscillating membrane displaces fluid to move blood. This design aims to provide pulsatile blood flow while enabling a less invasive surgical approach due to its compact, membrane-based mechanism. Compared with traditional ventricular assist devices, Corwave emphasizes its unique wave membrane pumping method and tubular membrane components to deliver controlled blood flow with fewer procedural burdens. The company’s goal is to improve outcomes and reduce suffering for patients by offering durable, implantable cardiac support that lowers the pain and risks associated with invasive surgery.

About Corwave

Simplify's Rating
Why Corwave is rated
C
Rated C on Competitive Edge
Rated C on Growth Potential
Rated C on Differentiation

Industries

Hardware

Healthcare

Company Size

51-200

Company Stage

Series C

Total Funding

$112.7M

Headquarters

Clichy, France

Founded

2012

Get referred to Corwave

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • April 24, 2025 preclinical results cleared the path toward clinical trial initiation.
  • CorWave opened its Clichy manufacturing facility, signaling readiness for industrial deployment.
  • March 31, 2026 leadership hires in CTO and clinical affairs support execution.

What critics are saying

  • No first-in-human trial has started by May 2026, delaying revenue and validation.
  • One device failure in early clinical testing would cripple CorWave's platform thesis.
  • Medtronic's withdrawal left CorWave attacking a market with proven incumbents and slow adoption.

What makes Corwave unique

  • CorWave's wave-membrane LVAD mimics native cardiac pulsatility, unlike axial-flow rivals.
  • April 24, 2025 chronic in vivo data showed six-month operation and no thrombosis.
  • May 29, 2026 ISO 13485 certification covers design, production, distribution, and service.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$112.7M

Below

Industry Average

Funded Over

9 Rounds

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.
Series C Funding Comparison
Below Average

Industry standards

$50M
$40M
Figma
$50M
Medium
$62M
SeatGeek
$100M
Oura

Benefits

Meal Benefits

Health Insurance

Disability Insurance

Commuter Benefits

Paid Vacation

Paid Holidays

Flexible Work Hours

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

0%
BioSpace
Apr 24th, 2025
CorWave Announces Successful Completion of 6-Month Chronic In Vivo Study, Paving the Way for Clinical Trial Initiation

CorWave is developing an implantable LVAD (Left Ventricular Assist Device) driven by its proprietary breakthrough wave membrane pump technology.

Business Wire
Apr 2nd, 2025
CorWave Announces the Appointment of Dawn Sadlowski-Buisserez as Vice President of Operations to Support the Ramp-Up of Production

CorWave announces the appointment of Dawn Sadlowski-Buisserez as Vice President of Operations to support the ramp-up of production.

Cardiac Vascular News
Dec 5th, 2023
CorWave Announces the Appointment of Fairuz Hasni as Vice President Human Resources

CorWave announces the appointment of Fairuz Hasni as Vice President Human Resources.

European Hospital & Healthcare Management
Oct 10th, 2023
CorWave Inaugurates State-of-the-Art Manufacturing Facility Along the Seine River Near Paris

CorWave, a French company specializing in the development and manufacturing of innovative cardiac assist devices, has officially opened its new facility located along the Seine River in Clichy, near Paris.

MD+DI
Oct 9th, 2023
CorWave Opens Manufacturing Facility Near Paris

CorWave opens manufacturing facility near Paris.

Recently Posted Jobs

Sign up to get curated job recommendations

Corwave is Hiring for 6 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →